StratDeckEarly access
Hikma Pharmaceuticals
1629.00GBp+1.05%Share
HIK.LHealthcare · Drug Manufacturers - Specialty & Generic · UK
Makes generic and injectable medicinesHikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
StratDeck's view
Screener: HIK.L in the stock screener
- TrendNot listed
- ValueNot listed
- Room to runAbout room to run
- 12.7%
- SectorAbout the sector
- Strong
- Analysts' view
- —
Fundamentals
Yahoo Finance
Market cap4.45B
P/E12.4×
Forward P/E8.6×
Price / book1.85
Dividend yield3.99%
Revenue YoY+4.20%
EPS YoY-4.70%
Net margin11.3%
Return on equity15.4%
Beta0.60
52-week range1187.00–1865.0065/100
ADV (USD)9.67M
10d avg volume462K
Other stocks you may like
What's happening?
HIK.L is keeping pace with Healthcare this month The figures
- 1D
- +1.05%
- 7D
- +3.17%
- 1M
- +6.40%
- 3M
- +3.51%
- 6M
- +23.29%
- YTD
- +5.14%
What is the market expecting?
StratDeckCheaper than similar companies, and analysts expect the price to rise The figures
Value score vs Healthcare peers
93- Fwd P/E8.697
- P/B1.891
- Yield4.0%86
- P/E12.497
- Rev growth+4.2%24
Is the business delivering?
Sales are growing slower than at similar companies, and profit per share is down The figures
No reported quarters on file for this stock.
How does it compare?
Nearest in Healthcare on valueStratDeckHIK.L is better value than most Healthcare stocks The figures
What happens next?
Reports next on 25 Feb, in 135 days
Fundamentals
Market cap4.45B
P/E12.4×
Forward P/E8.6×
Price / book1.85
Dividend yield3.99%
Revenue YoY+4.20%
EPS YoY-4.70%
Net margin11.3%
Return on equity15.4%
Beta0.60
52-week range1187.00–1865.0065/100
ADV (USD)9.67M
10d avg volume462K
StratDeck's view
Screener: HIK.L in the stock screener
- TrendNot listed
- ValueNot listed
- Room to runAbout room to run
- 12.7%
- SectorAbout the sector
- Strong
- Analysts' view
- —
Other stocks you may like
Keep researching
Where next from HIK.L
Daily market updates
Get the brief
Get an interesting stock pick, updates on the AI sector, information on the biggest movers of the day, and more, in the Monday, Wednesday and Friday email.